Dr. Pavel Kielkowski
Gruppenleiter
Institut für Chemische Epigenetik (ICEM)
+49 89 2180-77756
Postanschrift:
Butenandtstr. 5-13
81377 München
Forschungsgebiete
Kurzlebenslauf
- Chemistry studies at UCT Prague.
- 2014 Ph.D., IOCB & Charles University, Prague.
- 2014-2019 Postdoctoral research, TUM, Munich.
- Since 2019 Independent research, LMU Munich.
Wichtige Publikationen
- Kielkowski, P., Buchsbaum, I., Kirsch, V., Bach, N., Cappello, S., Drukker, M., Sieber, S. (2019). FICD activity and AMPylation remodelling modulate human neurogenesis. bioRxiv DOI: 10.1101/787929.
- Kielkowski, P., Fanfrlík, J., Hocek, M. (2014). 7‐Aryl‐7‐deazaadenine 2′‐Deoxyribonucleoside Triphosphates (dNTPs): Better Substrates for DNA Polymerases than dATP in Competitive Incorporations Angewandte Chemie International Edition 53(29), 7552-7555.
- Kielkowski, P., Macíčková-Cahová, H., Pohl, R., Hocek, M. (2011). Transient and switchable (triethylsilyl)ethynyl protection of DNA against cleavage by restriction endonucleases. Angewandte Chemie International Edition 50(37), 8727-8730.